Chiron ends clinical trial of HIV treatment
BY Advocate.com Editors
October 24 2002 11:00 PM ET
Chiron Corp. announced Wednesday that it is ending the development of three compounds, including a recombinant form of interleukin-2 being studied in a Phase III trial for the treatment of patients with HIV. The company had been expected to complete the clinical trial, including patient follow-up, in 2007. Chiron is now reviewing data for a possible regulatory submission for approval of IL-2 only in a small subset of HIV-positive patients who do not receive any response to other anti-HIV medications. The company also stopped development of compounds intended to treat cystic fibrosis and hepatitis B.
- Op-ed: The Decade Masturbation Burst Out of the Closet Before I Did
- PHOTOS: Explore Genderqueer and Other Genders Beyond the Binary
- Antigay Activist: Buy My 'No Such Thing as Gay' Book
- Is the 'Not Gay No More' Guy for Real?
- Mississippi Marriage Ban Struck Down
- Federal Judge Rules for Marriage Equality in Arkansas